Re: Discussions

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Discussions

posted on Sep 15, 2010 11:39PM

Rather than go back and forth, I suggest we await the SEC decision on the No-Action request.

My stance on Rule 14a-11 remains unchanged, I was offering two scenarios for consideration.

There are many changes that can be made to a company's by-laws, and there is much ongoing discussion as to how amendments are able to reflect the impact of Rule 14a-11, director qualifications and or experience being examples.

Only actions will change the reality of the situation, not discussions, and in the meantime we await further information from the SEC.